These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1204278)

  • 21. Nabilone pharmacotherapy for cannabis dependence: A randomized, controlled pilot study.
    Hill KP; Palastro MD; Gruber SA; Fitzmaurice GM; Greenfield SF; Lukas SE; Weiss RD
    Am J Addict; 2017 Dec; 26(8):795-801. PubMed ID: 28921814
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A species comparison of the toxicity of nabilone, a new synthetic cannabinoid.
    Hanasono GK; Sullivan HR; Gries CL; Jordan WH; Emmerson JL
    Fundam Appl Toxicol; 1987 Aug; 9(2):185-97. PubMed ID: 2888699
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of delta9-tetrahydrocannabinol and cannabinol in man.
    Karniol IG; Shirakawa I; Takahashi RN; Knobel E; Musty RE
    Pharmacology; 1975; 13(6):502-12. PubMed ID: 1221432
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tolerance to marijuana-induced tachycardia in man.
    Gibbins RJ; McDougall J; Miles CG; Marshman JA
    Acta Pharmacol Toxicol (Copenh); 1976 Jul; 39(1):65-76. PubMed ID: 782158
    [No Abstract]   [Full Text] [Related]  

  • 25. Marijuana: dose-response effects on pulse rate, subjective estimates of potency, pleasantness, and recognition memory.
    Miller L; Cornett T; Drew W; McFarland D; Brightwell D; Wikler A
    Pharmacology; 1977; 15(3):268-75. PubMed ID: 325580
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The pharmacology of marihuana.
    Thomas R; Chesher G
    Med J Aust; 1973 Aug; 2(5):229-37. PubMed ID: 4744099
    [No Abstract]   [Full Text] [Related]  

  • 27. The Safety of Dronabinol and Nabilone: A Systematic Review and Meta-Analysis of Clinical Trials.
    Bajtel Á; Kiss T; Tóth B; Kiss S; Hegyi P; Vörhendi N; Csupor-Löffler B; Gede N; Hohmann J; Csupor D
    Pharmaceuticals (Basel); 2022 Jan; 15(1):. PubMed ID: 35056154
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical pharmacology of delta-9-tetra-hydro-cannabinol in healthy volunteers with polygraphic control].
    Deniker P; Boissier JR; Etevenon P; Ginestet D; Peron-Magnan P; Verdeaux G
    Therapie; 1974; 29(2):185-200. PubMed ID: 4848300
    [No Abstract]   [Full Text] [Related]  

  • 29. Dose effects of smoked marihuana on human cognitive and motor functions.
    Borg J; Gershon S; Alpert M
    Psychopharmacologia; 1975 Jun; 42(3):211-8. PubMed ID: 1161978
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Subjective changes with delta 9 trans-tetrahydrocannabinol in cannabis naive subjects].
    Dittrich A; Woggon B
    Int Pharmacopsychiatry; 1974; 9(3):138-51. PubMed ID: 4609941
    [No Abstract]   [Full Text] [Related]  

  • 31. Tolerance to marijuana: heart rate and subjective "high".
    Nowlan R; Cohen S
    Clin Pharmacol Ther; 1977 Nov; 22(5 Pt 1):550-6. PubMed ID: 913022
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effects of octreotide on experimental orthostatic neurogenic hypotension].
    Verwaerde P; Bordet R; Portolan G; Tran MA; Marques MA; Montastruc JL; Sénard JM
    Arch Mal Coeur Vaiss; 1996 Aug; 89(8):1097-1101. PubMed ID: 8949386
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Repeat administration of marihuana smoke to humans.
    Renault PF; Schuster CR; Freedman DX; Sikic B; de Mello DN
    Arch Gen Psychiatry; 1974 Jul; 31(1):95-102. PubMed ID: 4835990
    [No Abstract]   [Full Text] [Related]  

  • 34. [Benefits of an add-on treatment with the synthetic cannabinomimetic nabilone on patients with chronic pain--a randomized controlled trial].
    Pinsger M; Schimetta W; Volc D; Hiermann E; Riederer F; Pölz W
    Wien Klin Wochenschr; 2006 Jun; 118(11-12):327-35. PubMed ID: 16855921
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interactions in man of delta-9-tetrahydrocannabinol. II. Cannabinol and cannabidiol.
    Hollister LE; Gillespie H
    Clin Pharmacol Ther; 1975 Jul; 18(1):80-3. PubMed ID: 1097148
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety and efficacy of nabilone for acute chemotherapy-induced vomiting prophylaxis in pediatric patients: A multicenter, retrospective review.
    Polito S; MacDonald T; Romanick M; Jupp J; Wiernikowski J; Vennettilli A; Khanna M; Patel P; Ning W; Sung L; Dupuis LL
    Pediatr Blood Cancer; 2018 Dec; 65(12):e27374. PubMed ID: 30051617
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacology of the intraocular pressure (IOP) lowering effect of systemic dexanabinol (HU-211), a non-psychotropic cannabinoid.
    Beilin M; Neumann R; Belkin M; Green K; Bar-Ilan A
    J Ocul Pharmacol Ther; 2000 Jun; 16(3):217-30. PubMed ID: 10872919
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The abuse potential of the synthetic cannabinoid nabilone.
    Ware MA; St Arnaud-Trempe E
    Addiction; 2010 Mar; 105(3):494-503. PubMed ID: 20402993
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tetrahydrocannabinols and serum prolactin levels in man.
    Lemberger L; Crabtree R; Rowe H; Clemens J
    Life Sci; 1975 Apr; 16(8):1339-43. PubMed ID: 1094213
    [No Abstract]   [Full Text] [Related]  

  • 40. delta9-Tetrahydrocannabinol and dimethylheptylpyran induced tachycardia in the conscious rat.
    Osgood PF; Howes JF
    Life Sci; 1977 Nov; 21(9):1329-36. PubMed ID: 927033
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.